Objectives-To assess the accuracy and effectiveness of routine screening for vasa previa, to describe our experience, and to assess factors that contribute to missed cases of vasa previa.
1
First described by Lobstein 2 in 1801, this condition is of great importance because rupture of these vessels may result in fetal death or severe perinatal morbidity. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Until the advent of antenatal diagnosis, vasa previa carried an extremely high rate of perinatal death and was often not anticipated before the catastrophic rupture of the fetal vessels. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The introduction of antenatal ultrasound (US) has made it possible to diagnose vasa previa antenatally and to intervene by cesarean delivery before the rupture of membranes to prevent perinatal death. 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The largest study of vasa previa found a rate of perinatal death of 56% when vasa previa was not diagnosed antenatally. 10 Furthermore, among survivors, when the condition was not diagnosed antenatally, the median 1-and 5-minute Apgar scores were 1 and 4, respectively, compared with 8 and 9 among those with antenatal diagnosis. 10 A few prior studies found good outcomes when vasa previa was diagnosed antenatally and cesarean delivery performed before rupture of the membranes. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] However, only few large studies came from single institutions or groups, which has led to an inability to develop consistent guidelines. [15] [16] [17] [18] [19] [20] Consequently, it has been debated whether it is cost-effective to screen for vasa previa. [14] [15] [16] [17] [18] [19] [20] Concerns have also been raised about the accuracy and feasibility of screening for the condition. [14] [15] [16] [17] [18] [19] [20] At our institution, it has been our practice to routinely screen for vasa previa. This screening is by a 2-fold approach. First, in all patients, we attempt to visualize the placental cord insertion, whenever possible, using grayscale and color Doppler US. This approach is in keeping with current American Institute of Ultrasound in Medicine guidelines. 21, 22 In patients with a low-lying placenta and those with risk factors such as a low-lying placenta in the second trimester, multifetal gestations, pregnancies with velamentous cord insertions, pregnancies with bilobed or succenturiate lobed placentas, and those resulting from in vitro fertilization, we routinely perform transvaginal US examinations with color and pulsed wave Doppler imaging, examining the region overlying the cervix for vasa previa. 22 In addition, whenever a patient has a transvaginal scan for cervical length or another indication, we routinely sweep the region over the cervix with color and pulsed wave Doppler US. When there appear to be vessels over the cervix, we routinely use pulsed wave Doppler US to confirm a fetal waveform and thus verify the diagnosis of vasa previa (Figure 1 ). The goals of our study were to assess the accuracy and effectiveness of our strategy in diagnosing vasa previa, to describe our experience, and to assess factors that may have contributed to missed cases of vasa previa.
Materials and Methods
We conducted a retrospective descriptive study of all cases of vasa previa that delivered at our institution over the past 8 years (2009-2017) . Institutional Review Board approval was obtained from the Atlantic Health Institutional Review Board (project 930900-1) before commencement of our study. Our maternal-fetal medicine service consists of 8 perinatologists and 20 perinatal sonographers. We provide perinatal and US services to the Atlantic Health System in New Jersey. Deliveries at We defined vasa previa on US imaging as unprotected fetal vessels overlying or in close proximity to the cervical internal os, visible by transvaginal US, and within a distance of 4 cm of the internal os. To meet criteria for vasa previa, these vessels had to be shown to be fixed in the membranes; in addition, they had to be present on repeated examinations and to persist despite changes in the maternal position. We defined vasa previa clinically as vaginal bleeding at the time of rupture of membranes, accompanied by an immediate abnormal fetal heart rate tracing and ruptured velamentous vessels found at delivery.
Cases were ascertained from review of our US database and our labor and delivery database. We searched our US database from 2009 to 2017 using the diagnosis "vasa previa." In addition, we searched the hospital medical records and labor and delivery database using the same diagnosis. We then examined the US and obstetric medical records as well as the neonatal medical records. Data were analyzed with StatCalc software (Acastat Software, Winter Garden, FL). Descriptive statistics were calculated.
Results
We identified 39 patients with a diagnosis of vasa previa either antenatally or at the time of delivery. After review of the records, 4 cases were excluded. In 3 cases, the exclusions were because of resolution of secondtrimester vasa previa. In 1 case, we had a false-positive case that was found at delivery to have placenta previa rather than vasa previa. Thus, we identified a total of 35 cases of vasa previa. In the 3 cases that were excluded, we reviewed the prior scans to confirm that vasa previa had indeed been present in the second trimester. We had 4 additional patients with vasa previa diagnosed antenatally by US who remained pregnant at the time of manuscript submission. We did not include these cases in our analysis.
In all cases, the diagnosis of vasa previa was confirmed after birth by examination of the placenta and documentation of the unprotected/velamentous vessels. Photographs of the placentas were taken in most cases for verification. The placentas were also sent to pathology and the diagnoses verified.
We had approximately 56,000 deliveries at our hospital over the same period. This number gives a crude incidence of vasa previa of 1 per 1600 births. Patient demographics are given in Table 1 .
Most cases (33 of 35 [94.3%]) were diagnosed antenatally. Of those 33 cases that had their anatomy US examinations done by our maternal-fetal medicine group, all were diagnosed antenatally, giving a sensitivity rate of 100%. The remaining 2 cases that were not diagnosed antenatally did not have their US examinations by our group and did not follow our screening protocol.
All patients with a US diagnosis were admitted to the hospital antenatally ( Table 1 ). The 2 patients that did not have an antenatal diagnosis presented in labor at 36.5 and 41.1 weeks, respectively. The mean gestational age 6 SD at delivery of prenatally diagnosed cases was 34.9 6 1.69 weeks. The 2 cases that were not diagnosed prenatally had emergency cesarean deliveries during labor because of bleeding and fetal distress.
All cases diagnosed prenatally had steroids administered at a mean gestational age of 32 6 2.3 weeks. In most cases, a repeated rescue course of steroids was not given before delivery. Most cases in our study preceded the recent recommendations for steroids for late preterm 23 Those recommendations for late preterm steroids exclude patients who previously received steroids. All cases diagnosed prenatally had cesarean deliveries. Twenty-one of the 33 cases diagnosed antenatally (63.6%) were delivered electively. The remaining 12 had emergency cesarean deliveries before the planned delivery date. Of the 12 emergency deliveries, 8 were due to preterm labor; 2 were due to rupture of the membranes; and 2 were due to bleeding. No cases were delivered as emergencies due to nonreassuring fetal heart rate tracings.
Both of the cases that were not diagnosed antenatally were delivered in labor at dilatation of 8 cm. In both cases, there was bleeding at the time of rupture of the membranes, with emergency cesarean deliveries. Median Apgar scores of the 33 cases diagnosed prenatally were 9 (range, 6-9) and 9 (range, 7-9) at 1 and 5 minutes, respectively. For the 2 cases that were not diagnosed prenatally, Apgar scores were 4 at 1 minute and 5 at 5 minutes for the first case, and 6 at 1 minute and 9 at 5 minutes for the second case.
The mean birth weight was 2416 6 430 g. The median time spent in the neonatal intensive care unit was 6.5 days (range, 0-61 days). Ten of 39 neonates developed respiratory distress syndrome. Three of the 39 neonates were intubated at birth. These were all twins. There were no serious neonatal complications among the cases diagnosed prenatally. The cases that were not diagnosed prenatally both required transfusions and prolonged hospitalization. None of the cases diagnosed prenatally required transfusions.
Discussion
Our study demonstrates that vasa previa, when diagnosed prenatally, is generally associated with excellent outcomes. We showed a high rate of prenatal diagnosis (100%) using our screening strategy. The 2 cases that were undiagnosed did not follow our screening strategy.
The strengths of our study include the single maternal-fetal medicine practice that used a uniform protocol for screening for vasa previa. Our protocol consists of routinely identifying the placental cord insertion in all pregnancies. In cases in which there is a low-lying placenta in the second trimester, we ask the patient to return at 28 to 32 weeks for a transvaginal scan with Doppler US, since a resolved placenta previa or lowlying placenta are risk factors for development of vasa previa. 1 We 22 The American Institute of Ultrasound in Medicine guidelines also recommend locating the placental cord insertion, whenever technically possible, at the time of the anatomy scan. 21 Based on our experience, if these guidelines are followed, the overwhelming proportion of cases of vasa previa will be diagnosed prenatally. At our institution, in addition to these guidelines, we routinely use color Doppler US over the cervix when a transvaginal US examination is done in pregnancy for cervical length measurement.
A cervical length assessment is increasingly performed to assess the risk of preterm birth, especially in those with risk factors. Risk factors include prior preterm birth, those with prior cervical surgery, and women with uterine anomalies. Routinely adding color Doppler US to these scans will help identify women who have vasa previa.
Two cases of vasa previa were missed. In neither did the patients have their anatomy scans at our maternal-fetal medicine practice. In the first case, rupture of membranes occurred when the patient was at 8 cm of dilatation. There was immediate vaginal bleeding accompanied by sudden fetal bradycardia. Fortunately, because of the vigilance of the obstetric team, this condition was recognized immediately. An emergency cesarean delivery was performed, and the neonate did well, even though the fetal vessels were ruptured. The neonate was profoundly anemic at birth and received an immediate blood transfusion, resulting in a favorable outcome. In the second case, vessels running transversely across the cervix were not recognized on the transvaginal US examination ( Figure 2) . Rupture of membranes resulted in bleeding, and an emergency cesarean delivery was performed. The neonate was also born profoundly anemic, with Apgar scores of 4 and 5 at 1 and 5 minutes.
Our study demonstrates several other important findings. First, some cases of vasa previa will resolve. Three cases resolved in our study. However, extreme caution must be exercised to ensure that resolution has actually taken place. This process requires repeated transvaginal US examinations with the fetal head elevated to ensure that vessels are not being compressed.
Second, vasa previa may be missed even when transvaginal US with Doppler imaging is used. One of the 2 missed cases was not identified despite transvaginal US with Doppler imaging at 38 weeks because of a previously noted second-trimester low-lying placenta. This patient did not have her anatomy scan at our center and did not follow our screening protocol. In this case, vessels running transversely across the cervix were not identified (Figure 2 ). Although most cases of vessels that run sagittally over the cervix will be easily identified, those that cross the cervix transversely require vigilance and a high degree of suspicion. Most practitioners are used to assessing the cervix in a sagittal plane. When vessels run sagittally, they will appear as linear structures (Figure 3) . However, vessels running transversely will appear as small circular hypoechoic structures on sagittal transvaginal sonograms, and can be easily missed (Figure 2) . In only 1 other case (which followed our screening protocol) were vessels seen running transversely over the cervix. Fortunately, that case was diagnosed prenatally because of the vigilance of the sonographer, who recognized those vessels.
Third, in a high proportion (10 of 39) of cases of vasa previa, the neonates developed respiratory distress syndrome, despite almost universal administration of steroids. In our study, most cases preceded the recent guidelines recommending steroid administration for late preterm deliveries at 34 weeks to 36 weeks 6 days. 23 It would be interesting in future studies to examine whether this policy would decrease respiratory morbidity in neonates delivered for vasa previa. The timing of delivery for patients with vasa previa is a matter of controversy. 24 Several have urged early delivery at 32 to 34 weeks. 24 However, high rates of respiratory distress syndrome and other morbidities exist in these neonates. Nine of those neonates with an antenatal diagnosis were delivered at 36 weeks. Our data suggest that in the absence of labor, bleeding, contractions, or rupture of the membranes, patients with vasa previa may be safely delivered at 35 to 36 weeks. Recent data have suggested that late preterm deliveries may be associated with an increased risk of neonatal morbidities; thus, prolongation of pregnancy, as long as it is safe, is desirable. It is our opinion that the recommendations for delivery at 34 weeks may be too early in stable patients, with increased risks to the neonate.
It is our opinion that almost all cases of vasa previa may be diagnosed prenatally if the cord insertion is routinely imaged during the anatomy scan. In cases with other risk factors, such as a second-trimester low-lying placenta, transvaginal US with Doppler imaging will detect most cases of vasa previa. We also believe that if Doppler US is used routinely over the cervix when cervical length measurements are taken, almost all cases of vasa previa will be diagnosed prenatally. Risk factors for vasa previa have previously been identified. These include a second-trimester low-lying placenta, pregnancies resulting from in vitro fertilization, multifetal gestations, and those with placentas that have accessory lobes. [25] [26] [27] Our fourth important finding is that some cases will occur in the absence of risk factors. We did identify 1 case with a normal cord insertion and without a secondtrimester low-lying placenta in which velamentous vessels ran a considerable distance from the edge of the placenta over the cervix (Figure 4 ). In this case and in 4 others (a total of 5 cases [14.3%]), there were no known risk factors for vasa previa.
All cases diagnosed antenatally were admitted to the hospital. Interestingly, 12 of 33 (36.4%) patients with a prenatal diagnosis and in the hospital still required emergency delivery. For this reason, we do not think it is appropriate that patients with vasa previa should be treated as outpatients in the late third trimester.
Admission to the hospital allows access to urgent delivery, whereas fetal demise could occur in patients treated as outpatients because of the time it would require to return to the hospital.
The distance from the vessels to the internal os for making the diagnosis of vasa previa has been an issue of some debate. Although some have used a distance of 2 cm to define vasa previa, this measurement has been extrapolated from experience with placenta previa in which a distance of 2 cm was found to be safe for vaginal delivery. 28, 29 The cervix dilates to 10 cm, and vessels within a 5-cm radius of the internal os are potentially at risk for rupture. Although all our patients had their vessels within 2 cm of the internal os, we would urge caution in using a 2-cm measurement to define vasa previa. It is our opinion that patients with vessels between 2 and 5 cm from the internal os should be counseled about potential risks and their management decided on a caseby-case basis with full informed consent. If these patients undergo a trial of vaginal birth, bleeding, abnormal fetal heart tracings, or both must be recognized promptly, with a low threshold for cesarean delivery. Unfortunately, a study that would demonstrate a "safe distance" would be impossible to conduct.
Whether routine screening for vasa previa is clinically possible or cost-effective has been a matter of great debate. It has been argued that screening for vasa previa may make unacceptable demands on personnel and resources. Furthermore, it has been argued that falsepositive and -negative results may occur. However, recent guidelines recommend an attempt to visualize the placental cord insertion, when feasible, as part of the routine-second trimester anatomy scan, and in patients who have a second-trimester low-lying placenta, a transvaginal US examination with Doppler imaging should be performed at about 32 weeks to screen for vasa previa. 22 In our opinion, this approach constitutes adequate screening for vasa previa and will detect almost all cases.
In a 1998 study of 587 patients, Nomiyama et al 30 found that 99% of placental cord insertions could be found, most of them were found within 20 seconds. Sepulveda et al 31 had similar success with attempting to routinely identify placental cord insertions. Thus, this strategy does not add substantially to resources, personnel, or time other than what are already in use and can help prevent perinatal death in otherwise healthy neonates.
Few conditions have as high a perinatal mortality as ruptured undiagnosed vasa previa. Furthermore, most of the adverse outcomes resulting from rupture of vasa previa are preventable. In health care, many resources are spent on conditions in which prenatal diagnosis may have little impact on outcomes.
Perhaps the most important goal of prenatal care and obstetric US is to prevent stillbirth and perinatal morbidity. Prenatal US has become almost universal in the western world. Given that vasa previa, when not diagnosed prenatally, is associated with a perinatal death rate of at least 56%, whereas survival after prenatal diagnosis approaches 100%, we find it inconceivable that an argument is still made against universal screening for vasa previa, especially since estimates of the incidence of vasa previa range from 1 per 500 to 1 per 2000. Vasa previa may be more frequent; Hasegawa et al 32 found an incidence of 1 per 365 pregnancies. Certainly, we routinely screen for much less common conditions in which prenatal diagnosis has little or no impact on survival. To put it in perspective, omphalocele occurs in 1 per 5400 births, anencephaly 1 per 5000 births, gastroschisis 1 per 2400 births, spina bifida 1 per 2858 births, and tetralogy of Fallot 1 per 3333 births, yet no one would think of suggesting that we do not screen for these conditions.
Our findings demonstrate that most cases of vasa previa can be diagnosed prenatally by following the consensus guidelines for fetal imaging, and deaths from this condition are almost universally preventable. Our findings support routine screening for vasa previa. It is one condition in which prenatal diagnosis by US will almost universally lead to good outcomes and prevent perinatal mortality.
Authors' Addendum
Since submission of the manuscript, a further 4 cases of antenatally diagnosed vasa previa have delivered by elective cesarean with favorable perinatal outcomes, and we have diagnosed another 3 patients who are yet to deliver.
